Regenerative Medicine Market to Surpass USD 153.05 Billion by 2029, With 26.3% CAGR

According to Fortune Business Insights, the global Regenerative Medicine Market size is projected to reach USD 153.05 Billion by 2029, at a CAGR of 26.3% during the forecast period, 2022-2029

Pune, India, Feb. 13, 2023 (GLOBE NEWSWIRE) — The regenerative medicine market size was valued at USD 23.65 billion in 2021. The market is expected to grow from USD 29.86 billion in 2022 to USD 153.05 billion by 2029 with a CAGR of 26.3% during the forecast period. Rising cases of chronic genetic disorders are expected to open a new set of opportunities, thereby driving the market growth. Increasing application in cardiology, neurology, oncology, and others is expected to propel the market course. Growing number of initiatives and investments for research is projected to assist in the market development. Fortune Business Insights™ shares this information in its report titled “Regenerative Medicine Market, 2022-2029.”

Key Industry Development

June 2022- Bristol Myers Squibb Company received the U.S. FDA approval for CAR T cell Therapy Breyanzi. It is for people who have primary refractory or relapsed Large B-cell Lymphoma (LBCL) who cannot have transplants.

Get a Free Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/sample/regenerative-medicine-market-100970

Report Scope:

Drivers and Restraints

Increased Number of R&D Activities in New Therapies to Propel Market Development

Increasing number of investments in R&D activities that focus on new therapies and products is anticipated to drive the regenerative medicine market growth. This will pave the way for important mergers, partnerships, and research collaborations. Various private and government players and research institutes have been introducing options to treat various chronic diseases such as cancers, Parkinson’s disease, diabetes, renal diseases, cardiovascular diseases, and others. Various applications of the product in cardiology, neurology, oncology, and others are expected to drive the market growth.

However, high treatment costs and insufficient policies for reimbursement are expected to hamper the market growth.

Key Takeaways: 

• Key drivers propelling the market’s expansion include the rising incidence of blood malignancies, initiatives to cure uncommon diseases, and the growing need for individualised care.
• The global market is segmented based on product into platelet rich plasma, tissue engineering, gene therapy, and cell therapy.
• The industry with the most market share in 2021 was cell therapy.
• The North American market, which was estimated at $10.50 billion in 2021, is expected to continue to dominate during the projection period.
• Since purchasing Wright Medical Group N.V., Stryker has dominated the global market for tissue engineering.

Browse Complete Report: https://www.fortunebusinessinsights.com/industry-reports/regenerative-medicine-market-100970

Segments

Cell Therapy to Lead Due to Increasing Benefits in Treatment Diseases

On the basis of product, the market is segmented into cell therapy, gene therapy, tissue engineering, and platelet rich plasma. Cell therapy accounted for the largest part in 2021 owing to increasing benefits in treating diseases such as autoimmune diseases, cancers, infectious diseases, and joint injuries.

Orthopedics to Head the Segment Due to Increasing Prevalence of Osteoarthritis

Based on application, the market is categorized into orthopedics, wound care, oncology, rare diseases, and others. Orthopedics segment held the maximum global regenerative medicine market share in 2021 due to gradual increase in the prevalence of osteoarthritis and bone related injuries.

To Get This Report Customized, Visit: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/regenerative-medicine-market-100970

Hospitals to Head Due to Increasing Number of Surgeries

Based on distribution channel, the market is segmented into hospitals, clinics, and others. Hospitals segment is expected to dominate the market during the forecast period due to increasing number of surgeries and government support and initiatives.

Report Coverage

The report provides a detailed analysis of the top segments and the latest trends in the market. It comprehensively discusses the driving and restraining factors and the impact of COVID-19 on the market. Additionally, it examines the regional developments and the strategies undertaken by the market’s key players.

Regional Insights

North America to Lead the Market Owing to Increasing Technological Innovations

North America is expected to dominate the market share due to technological innovations, rapid adoption of cell and gene therapy, and new product approvals.

Europe is anticipated to have the second largest market share in the forecast period due to emergent guidelines of government and therapies. Presence of numerous research institutes and increasing government funding are expected to boost the market growth in Europe.

Asia Pacific is projected to grow with maximum CAGR due to the rising cases of chronic diseases, government initiatives for technological advancements, and improving disposable incomes.

Competitive Landscape

Partnership Strategies by Key Players to Progress Market Route

Partnership strategies by the regenerative medicine players are predicted to progress market grip. In terms of cell and gene therapy, Gilead Sciences Inc. and Novartis AG are dominant companies in these segments due to CAR T-cell therapy pipeline. In August 2022, bluebird bio received the FDA approval for Zynteglo (betibeglogene autotemcel). It is the first cell-based gene therapy that can be used for treating adult and pediatric patients suffering from beta-thalassemia who regularly require red blood cell transfusions.   

Ask An Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/regenerative-medicine-market-100970

List of Key Players Profiled in the Report

• Integra LifeSciences Corporation (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Tissue Regenix (U.K.)
• Smith & Nephew (U.K.)
• MIMEDX (U.S.)
• Novartis AG (Switzerland)
• Allergan Aesthetics (AbbVie Inc.) (U.S.)
• Stryker (U.S.)
• American CryoStem Corporation (U.S.)
• Kite (Gilead Sciences, Inc.) (U.S.)
• AlloSource (U.S.)
• bluebird bio, Inc. (U.S.)
• CRISPR Therapeutics (Switzerland)
• Janssen Global Services, LLC (Johnson & Johnson Services, Inc.) (Belgium)
• Tegoscience (South Korea)

Table of Content:

• Key Insights
  • Global Financing of Companies Active in Regenerative Medicine
  • Prevalence of Chronic Diseases, by Key Countries/Regions, 2021
  • Pipeline Analysis, By Key Players
  • New Product Launches
  • Key Industry Developments: Mergers, Acquisitions & Partnerships
  • Technological Developments
  • Impact of COVID-19 on the Global Regenerative Medicine Market
• Global Regenerative Medicine Market Analysis, Insights and Forecast, 2018-2029
  • Market Analysis, Insights and Forecast – By Product
    • Cell Therapy
    • Gene Therapy
    • Tissue Engineering
    • Platelet Rich Plasma
  • Market Analysis, Insights and Forecast – By Application
    • Orthopedics
    • Wound Care
    • Oncology
    • Rare Diseases
    • Others
  • Market Analysis, Insights and Forecast – By Distribution Channel
    • Hospitals
    • Clinics
    • Others
  • Market Analysis, Insights and Forecast – By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

• TOC Continued…!

Request a Complete TOC: https://www.fortunebusinessinsights.com/industry-reports/toc/regenerative-medicine-market-100970

Explore Trending Reports of Fortune Business Insights:

Gene Therapy Market Share, Revenue Forecast and Opportunities

Bone Void Fillers Market Size, Share, Opportunities & Analysis

Molecular Diagnostics Market Overview, Industry Share and Forecast

Diabetes Devices Market Share, Revenue Forecast and Opportunities

Prefilled Syringes Market Size, Share, Opportunities & Analysis

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com